Please login to the form below
women
This page shows the latest women news and features for those working in and with pharma, biotech and healthcare.
CHMP backs Sanofi’s all-oral sleeping sickness drug
Among these, Novartis’CDK4/6 inhibitor Kisqali (ribociclib) was recommended for the treatment of women with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer in combination with fulvestrant ... as initial
Latest news
-
AbbVie preps uterine fibroid filing after phase 3 win
In the first trial, 68.5% of women on elagolix achieved the threshold clinical response to treatment, compared to 8.7% of the placebo group. ... In many cases they cause no symptoms, but around a quarter of women experience pain, abnormal bleeding and
-
Democrats regain control of House in mid-terms
3rd District for example, which saw two-time Republican incumbent Kevin Yoder ousted by Democrat Sharice Davids – one of two Native American women joining Congress for the first time this year –
-
ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers
INNOVO, which restores pelvic-floor control and treats stress incontinence, proved that after 12 weeks’use, 87.2% of women returned to a dry or mild category of stress incontinence severity.
-
MS and cholesterol drugs picked for new UK rapid uptake push
Placental growth factor (PIG-F) based testing for suspected pre-eclampsia - tests for early diagnosis of pre-eclampsia in pregnant women, which if unmonitored, can cause serious complications for mother and
-
AZ and Clovis PARP inhibitors show their mettle at ESMO
While it is too early to say whether we have impacted the fraction of women who could be cured with their front-line therapy, the fact that it is estimated that ... over 50% of women on the olaparib arm were still progression free at four years as
More from news
Approximately 6 fully matching, plus 912 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
acquisition. In a third, widely reported rumour, Pfizer is said to be looking at divesting its women’s health division, which includes the product Premarin for the menopause. ... Given that Teva divested its women’s health division for $1.38B earlier
-
Tackling a formidable foe
Invest in more research. “Most of the MS patients are young women and one important consideration for patients is to be able to plan for pregnancy.
-
‘Flexible working’: fashionable buzzword or fundamental business operation?
There are various theories on why this is, including the fact that women make circa 80% of the healthcare decisions for their families and that good healthcare communications demands some of
-
Diversity and inclusion in the pharma industry
This is even more surprising as I don’t work at the ‘bench face’of science where the shortage of women is now acknowledged, but on the marketing side of the ... the bonus pay gap, it’s not unusual to find that gap between women’s and men’s
-
Is flexible working the future?
Our members, both men and women, have made an active choice to work differently, for a whole host of reasons and the Collective allows them to be life-flexible, however they ... In April, the House of Commons Women and Equalities Committee highlighted
More from intelligence
Approximately 6 fully matching, plus 77 partially matching documents found.
Latest appointments
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
In addition to her executive positions at Amgen, Hamill served as a board member of the Amgen Foundation and was the executive leader of the company’s Senior Women’s Advisory ... She also currently serves on the advisory board of the Women Business
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult, Filippo Petti joins Ceylad and Vivienne Fox to chair RFI
During her time with BP, Vivienne was regularly listed in Fortune magazine’s ‘World’s 50 Most Powerful Women in Business’.
-
Lilly bolsters its oncology team
oncology. Blackwell currently serves as a professor of medicine and assistant professor of radiation oncology at Duke University Medical Center, and she is also the co-director of the Duke
-
Topas Therapeutics appoints chief development officer and chief medical officer
Prior to that, he held several roles at Bayer, including vice president, head of experimental medicine of women’s health and common mechanism research.
-
Anish Mehta appointed CEO of new women's health business
Anish Mehta appointed CEO of new women's health business. Will head up the former Teva portoflio CVC Capital Partners recently acquired. ... The combination of high quality products and a talented team creates a unique opportunity for us to build a
More from appointments
Approximately 0 fully matching, plus 31 partially matching documents found.
Latest from PMHub
-
U.S. Intrauterine Devices Market Rising at 7.5% CAGR During 2018-2024: Market Study Report
The increase in inclination of women in the country towards hormonal contraception will boost the U.S. ... The rise in awareness will increase the number of women opting for effective reversible contraceptive such as intrauterine devices.
-
Global Breast Pump Market is anticipated to grow at a CAGR of 7.5% by 2024
Improving healthcare infrastructure and escalating rate of women employment are factors driving breast pump market growth. ... Increasing adoption of breast pump and favorable reimbursement coupled with surging demand from working women are factors
-
Utrasound Doppler Market Prevalent Opportunities upto 2026
It can also be used for detecting breast cancer and the American Cancer Society and Radiological Society of North America recommends periodic mammographic screening to women above the age of 40
-
MRI Transport Market Likely to Emerge over a Period of 2016-2026
The report also says that in the US in an average 66 percent men and approximately 92 percent women die every year because of some kind of neurological ailment. ... More than 48 percent women of UK and 32 percent men of UK are victims of some sort of
-
Worldwide Contraceptives Market Growing at a CAGR of 6.8% to 2024: Market Study Report
Request a discount on standard prices of this premium report at: . Availability of the national health insurance scheme for women under the age of 18 covering UTI and emergency contraception completely,
More from PMHub
Approximately 7 fully matching, plus 100 partially matching documents found.
Featured jobs
-
Medical (Scientific) Director
-
£120, 000 benefits
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Systematic Reviewer - Oxford
-
Negotiable
- Principal Health Economist - North-West
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
-
Account Manager
-
Negotiable
- Business Development Director – Health Education
-
excellent commission
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Business Director
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
- Industry frustrated by late warning on 'no deal' Brexit disruption
- UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
- Lucid Group celebrate another magical year at their Winter Meeting
- Biogen picks up another drug from wide-ranging Ionis alliance
- As France protests, Sanofi takes axe to 670 jobs
- Leicester NHS Trust’s staff intranet is integral to HCPs’ working day
PMHub
Conversis
Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...
Latest intelligence
- Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
- What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
- What everyone forgets about good organisational change in pharma
- Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
- Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
- Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...
Quick links
Infographics
